Anti-N-acetylprocainamide Antibody (16908)

Anti-N-acetylprocainamide Antibody (16908)

Product No.: 16908

- -
- -
Clone
NAPA11-128.2.1
Target
N-Acetylprocainamide
Formats AvailableView All
Product Type
Monoclonal
Isotype
Mouse IgG1
Applications
ELISA

- -
- -
Select Product Size

Data

These antibodies recognize N-Acetylprocainamide and cross-react to different degrees with procainamide|N-Acetylprocainamide (NAPA) is the N-acetylated metabolite ofprocainamide.These antibodies recognize N-Acetylprocainamide and cross-react to different degrees with procainamide.
N-Acetylprocainamide (NAPA) is the N-acetylated metabolite of procainamide.
- -
- -

Antibody Details

Product Details

Reactive Species
N-Acetylprocainamide
Host Species
Mouse
Immunogen
N-Acetylprocainamide-KLH.
Product Concentration
Lot Specific
Formulation
This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added.
State of Matter
Liquid
Product Preparation
Antibodies are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
Upon initial thawing, appropriately aliquot and store at -80°C. For long-term storage, keep at -80°C. Avoid repeated freeze-thaw cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
These antibodies have been qualified for use in ELISA to detect N-Acetylprocainamide.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
This mouse monoclonal antibody is specific to N-acetylprocainamide and shows 2.4% cross-reactivity with procainamide.
Background
N-Acetylprocainamide (NAPA) is the N-acetylated metabolite of procainamide. It is a Class III antiarrhythmic agent and only partially as active as procainamide. NAPA is a potassium-channel blocker and binds to potassium channels. The electrophysiologic properties of NAPA are slightly different from those of procainamide, but its antiarrhythmic mechanisms are similar to those of procainamide.
Research Area
Drugs

References & Citations

Indirect Elisa Protocol

Certificate of Analysis

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.